| Search for content and authors |
|
|
| |
 |
dr Elżbieta U. Stolarczyk
|
| e-mail: | ***@ifarm.eu |
| phone: | |
| fax: | |
| web: | |
| interest(s): | |
|
Affiliation: |
Instytut Farmaceutyczny |
Participant: |
|
Participant: |
|
Participant: |
|
Participant: |
|
Participant: |
|
Publications: |
- APPLICATION OF GC/MS FOR IDENTYFICATION OF THE SIDEPRODUCTS IN A PROCESS OF PREPARATION OF PRAMIPEXOLE.
- Development and validation of GCMS method for the control of ethyl and izopropyl methanesulphonates in pharmaceutical substance in a form of mesilate
- Development and validation of the GC method for quantitative determination of semi-volatile solvents in pharmaceutical substance Bosentan
- GC METHOD FOR QUANTITATIVE DETER- MINATION OF RESIDUAL 2-(2-CHLORO- ETOXY)ETHANOL (CEE) AND N-METHYL- 2-PYRROLIDINONE (NMP) IN PHARMACEU- TICAL ACTIVE SUBSTANCE
- Investigation of unknown impurities in cyclic dermorphin analogue by HPLC-MS
- Isolation, structural elucidation and characterization of impurities in latanoprost
- Method development and validation of an analytical procedure - control of residual 2-iodopropane in Latanoprost
- NEW SYNTHESIS OF 11-(1-PIPERAZINYL)- DIBENZO[b,f][1,4]THIAZEPINE, A CRUCIAL INTERMEDIATE IN QUETIAPINE PRODUCTION.
- The use of the hyphenated LC-MS/MS technique for the characterisation of impurity profile of Quetiapine during drug development
|
